Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients.
about
Antidepressant prophylaxis reduces depression risk but does not improve sustained virological response in hepatitis C interferon recipients without depression at baseline: a systematic review and meta-analysisAdherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirinPegylated interferon-α2a and ribavirin versus pegylated interferon-α2b and ribavirin in chronic hepatitis C : a meta-analysis.Review article: adherence to medication for chronic hepatitis C - building on the model of human immunodeficiency virus antiretroviral adherence researchAdherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users.Reliability and validity of a self-efficacy instrument for hepatitis C antiviral treatment regimens.Altered Monoamine and Acylcarnitine Metabolites in HIV-Positive and HIV-Negative Subjects With Depression.Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute?Recognizing cognitive and psychiatric changes in the post-highly active antiretroviral therapy era.Adherence to PEG/ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistence.Impact of hepatitis C treatment initiation on adherence to concomitant medications.Adherence in liver transplant recipients.HIV and depression--a systematic review of interventions.Patient Characteristics Associated with HCV Treatment Adherence, Treatment Completion, and Sustained Virologic Response in HIV Coinfected Patients.Depression in HIV and HCV co-infected patients: a systematic review and meta-analysis.Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney Disease.Pegylated alpha-interferon-2a plus ribavirin compared with pegylated alpha-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: prospective, non-randomized study.Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study.
P2860
Q26864986-A7D90031-A8C9-4052-BE42-20D83D634312Q33795847-585D3CDF-44C9-48B7-9BDA-1DC73B9064ACQ33936783-43E6DE31-D40E-4E30-9E87-844B433587FFQ34329513-895D202B-AAB2-4262-99A1-AB066DFC74B4Q35008754-1B554BB4-88C8-4D6F-9166-EC12AE80C7B1Q35053344-5FACDE4F-CA5C-4383-8569-0FAAB2155E86Q35906682-1548F49E-EF9D-49CE-A151-95D53CBC5416Q36036109-C28C81AB-72FA-4872-96DB-5DE159889F82Q36418455-6908A5D3-3E07-4847-83CC-517267BC1815Q36684274-B1A4A98B-8837-4EBB-B162-1CB68D428867Q36990416-6FDF49F2-66D2-4DDF-971B-3F814F75CCECQ37626270-D6546A5E-3E56-43B3-A0EA-C7D49E09648AQ37850768-11D9D448-D6B5-4EF7-95D2-B21C282738A9Q37910199-164D6D14-7824-4BE9-8A3D-4342DCBA93B1Q38894961-67212F78-3008-44BD-BB6D-91C57136BAC2Q39093985-B255C67F-9955-4373-9874-C2BD58139872Q40481281-45FF3E6D-E4CE-4CC6-923E-E73700357A89Q42977862-CD43C737-AA77-4434-AA0A-9B26BF4343A5Q46546968-8FBF8B50-89F4-4815-9762-A939FE2EF259
P2860
Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Influence of the type of pegyl ...... n HIV-HCV coinfected patients.
@en
Influence of the type of pegyl ...... n HIV-HCV coinfected patients.
@nl
type
label
Influence of the type of pegyl ...... n HIV-HCV coinfected patients.
@en
Influence of the type of pegyl ...... n HIV-HCV coinfected patients.
@nl
prefLabel
Influence of the type of pegyl ...... n HIV-HCV coinfected patients.
@en
Influence of the type of pegyl ...... n HIV-HCV coinfected patients.
@nl
P2093
P2860
P50
P1433
P1476
Influence of the type of pegyl ...... in HIV-HCV coinfected patients
@en
P2093
A L Ballesteros
E Masmitjà
M J Ferrer
P2860
P304
P356
10.1080/09540120600645539
P577
2007-01-01T00:00:00Z